We are live on
!
Find out more
VM
VV Manager Portfolio holdings
AUM
$114M
1-Year Est. Return
59.16%
This Fund
S&P 500
This Quarter
Est. Return
+5.15%
1 Year Est. Return
+59.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$233M
AUM Growth
–
Cap. Flow
+$232M
Cap. Flow
% of AUM
99.66%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Allogene Therapeutics
ALLO
|
+$204M |
| 2 |
Q32 Bio
QTTB
|
+$16.2M |
| 3 |
Sutro Biopharma
STRO
|
+$12M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
MCM
GTP
APG
LM
VPMV
CCM
CCM
BWM
VV Manager's Q4 2018 Portfolio in Review
Q4 2018 is the first quarter with a 13F filing on record for VV Manager, which disclosed 3 positions worth $233M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Allogene Therapeutics: 7,681,133 shares worth $207M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- VV Manager's largest Q4 2018 buy was Allogene Therapeutics: 7,681,133 shares worth $207M.
- VV Manager's ten largest holdings make up 100% of its $233M portfolio in Q4 2018.
- VV Manager disclosed 3 positions in Q4 2018, its first 13F filing on record.
Based on VV Manager's 13F filing for Q4 2018, filed 27 Feb 2019.